ORIGINAL RESEARCH article
Front. Mol. Biosci.
Sec. Molecular Diagnostics and Therapeutics
Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1587196
This article is part of the Research TopicTransforming Chronic Disease Treatment with AI and Big DataView all articles
Identification of key genes CCL5, PLG, LOX and C3 in clear cell renal cell carcinoma through integrated bioinformatics analysis
Provisionally accepted- 1Department of Urology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China
- 2Department of Kidney Transplantation, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
- 3Department of Thyroid and Galactophore Surgery, People's Hospital of Longhua,, Shenzhen, China
- 4Department of Urology, Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Clear Cell Renal Cell Carcinoma (ccRCC) is a malignant tumor with high mortality and recurrence rates and the molecular mechanism of ccRCC genesis remains unclear. In this study, we identified several key genes associated with the prognosis of ccRCC by using integrated bioinformatics.Methods: Two ccRCC expression profiles were downloaded from Gene Expression Omnibus (GEO), and one dataset was gained from The Cancer Genome Atlas (TCGA). The Robust Rank Aggregation (RRA) method was used to analyze the three datasets to gain integrated differentially expressed genes (DEGs). The GO and KEGG analysis were performed to explore the potential functions of DEGs. The Search Tool for the Retreival of Interacting Genes/Proteins (STRING) and Cytoscape software were used to construct PPI network and module analyses to screen the hub genes.Spearman's correlation analysis was conducted to evaluate the interrelationships among the hub genes. The prognostic value was evaluated through K-M survival analysis, Cox regression analysis, and receiver operating characteristic (ROC) curve analysis to determine their potential as prognostic biomarkers in ccRCC. The expression of hub genes between ccRCC and adjacent normal tissues was analyzed by RT-qPCR, Western blotting, and immunohistochemical (IHC).Result: 125 DEGs were identified using the limma package and RRA method, including 62 up-expressed genes and 63 down-expressed genes. GO and KEGG analysis showed some associated pathways. Spearman's correlation analysis revealed that the hub genes are not only interrelated but also closely associated with immune cell infiltration. Gene expression analysis of the hub genes based on the TCGA-KIRC cohort, along with K-M survival analysis, Cox regression, and ROC curve analysis, consistently demonstrated that CCL5, LOX, and C3 are significantly upregulated in ccRCC and are associated with poor clinical outcomes. In contrast, PLG showed opposite result. These results were further validated at the mRNA and protein levels.Our findings indicate that CCL5, LOX, C3, and PLG are significantly associated with the progression and prognosis of ccRCC, highlighting their potential as prognostic biomarkers. These results provide a foundation for future research aimed at uncovering the underlying mechanisms and identifying potential therapeutic targets for ccRCC.
Keywords: ccRCC, integrated bioinformatics analysis, Hub genes, prognosis, biomarkers
Received: 04 Mar 2025; Accepted: 22 Apr 2025.
Copyright: © 2025 Deng, Zhenwei, Feng, Hong, Chen and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Weiming Deng, Department of Urology, The First Affiliated Hospital of University of South China, Hengyang, Hunan Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.